The OEM partnership will enable GenapSys customers turn-key access to Twist’s best-in-class target enrichment workflows, providing researchers with optimized assays spanning cancer test panels to ...
The COVID-19 pandemic put next-generation sequencing technology to the test—and GenapSys’ portable sequencer, for one, passed with flying colors. More than a year after being tapped by the Chinese ...
Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding of complex biological mechanisms. With these experiments on the rise, researchers must ...
Although next-generation sequencing (NGS) keeps giving—exploring the human genome and revolutionizing our knowledge of health and disease—it needs to take a little, too. At the very least, NGS ...
Next-generation sequencing (NGS) is increasingly employed to dive deeper into complex biological mechanisms in a myriad of disciplines. But as with most methodologies, the quality of the input ...